BRPI1008660A2 - derivados de n-[(2-aza-biciclo[2.1.1] hex-1-il)-aril-metil]benzamida, sua preparação e sua aplicação em teraêutica - Google Patents
derivados de n-[(2-aza-biciclo[2.1.1] hex-1-il)-aril-metil]benzamida, sua preparação e sua aplicação em teraêuticaInfo
- Publication number
- BRPI1008660A2 BRPI1008660A2 BRPI1008660A BRPI1008660A BRPI1008660A2 BR PI1008660 A2 BRPI1008660 A2 BR PI1008660A2 BR PI1008660 A BRPI1008660 A BR PI1008660A BR PI1008660 A BRPI1008660 A BR PI1008660A BR PI1008660 A2 BRPI1008660 A2 BR PI1008660A2
- Authority
- BR
- Brazil
- Prior art keywords
- arylmethyl
- aza
- bicyclo
- hex
- therapeutics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0900578A FR2941953B1 (fr) | 2009-02-10 | 2009-02-10 | Derives de n-°(2-aza-bicyclo°2.1.1!hex-1-yl)-benzamide, leur preparation et leur application en therapeutique |
| PCT/FR2010/050203 WO2010092286A1 (fr) | 2009-02-10 | 2010-02-09 | Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1008660A2 true BRPI1008660A2 (pt) | 2016-03-08 |
Family
ID=40935627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1008660A BRPI1008660A2 (pt) | 2009-02-10 | 2010-02-09 | derivados de n-[(2-aza-biciclo[2.1.1] hex-1-il)-aril-metil]benzamida, sua preparação e sua aplicação em teraêutica |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20120071536A1 (pt) |
| EP (1) | EP2396334A1 (pt) |
| JP (1) | JP2012517411A (pt) |
| KR (1) | KR20110118812A (pt) |
| CN (1) | CN102388049A (pt) |
| AR (1) | AR075379A1 (pt) |
| AU (1) | AU2010212702A1 (pt) |
| BR (1) | BRPI1008660A2 (pt) |
| CA (1) | CA2751863A1 (pt) |
| FR (1) | FR2941953B1 (pt) |
| IL (1) | IL214490A0 (pt) |
| MX (1) | MX2011008447A (pt) |
| RU (1) | RU2011137463A (pt) |
| SG (1) | SG173606A1 (pt) |
| TW (1) | TW201036979A (pt) |
| UY (1) | UY32428A (pt) |
| WO (1) | WO2010092286A1 (pt) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861070B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique |
| FR2861076B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique |
| WO2005058317A1 (en) * | 2003-12-18 | 2005-06-30 | Glaxo Group Limited | Glycine transporter-1 inhibirors |
| AU2006309050B2 (en) * | 2005-10-28 | 2012-08-16 | Merck Sharp & Dohme Corp. | Piperidine glycine transporter inhibitors |
| WO2009013535A1 (en) * | 2007-07-23 | 2009-01-29 | Astrazeneca Ab | 2-azabicyclo(2.2.2)octane derivatives as modulators of the glycine transporter i receptor |
-
2009
- 2009-02-10 FR FR0900578A patent/FR2941953B1/fr not_active Expired - Fee Related
-
2010
- 2010-02-09 AR ARP100100344A patent/AR075379A1/es unknown
- 2010-02-09 JP JP2011548758A patent/JP2012517411A/ja not_active Withdrawn
- 2010-02-09 AU AU2010212702A patent/AU2010212702A1/en not_active Abandoned
- 2010-02-09 CA CA2751863A patent/CA2751863A1/fr not_active Abandoned
- 2010-02-09 KR KR1020117021203A patent/KR20110118812A/ko not_active Application Discontinuation
- 2010-02-09 TW TW099104005A patent/TW201036979A/zh unknown
- 2010-02-09 MX MX2011008447A patent/MX2011008447A/es not_active Application Discontinuation
- 2010-02-09 CN CN2010800150193A patent/CN102388049A/zh active Pending
- 2010-02-09 US US13/148,583 patent/US20120071536A1/en not_active Abandoned
- 2010-02-09 RU RU2011137463/04A patent/RU2011137463A/ru unknown
- 2010-02-09 SG SG2011057205A patent/SG173606A1/en unknown
- 2010-02-09 EP EP10708303A patent/EP2396334A1/fr not_active Withdrawn
- 2010-02-09 WO PCT/FR2010/050203 patent/WO2010092286A1/fr active Application Filing
- 2010-02-09 BR BRPI1008660A patent/BRPI1008660A2/pt not_active Application Discontinuation
- 2010-02-10 UY UY0001032428A patent/UY32428A/es not_active Application Discontinuation
-
2011
- 2011-08-07 IL IL214490A patent/IL214490A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL214490A0 (en) | 2011-09-27 |
| RU2011137463A (ru) | 2013-03-20 |
| FR2941953A1 (fr) | 2010-08-13 |
| MX2011008447A (es) | 2011-11-29 |
| CN102388049A (zh) | 2012-03-21 |
| UY32428A (es) | 2010-09-30 |
| CA2751863A1 (fr) | 2010-08-19 |
| AU2010212702A1 (en) | 2011-09-01 |
| SG173606A1 (en) | 2011-09-29 |
| JP2012517411A (ja) | 2012-08-02 |
| EP2396334A1 (fr) | 2011-12-21 |
| FR2941953B1 (fr) | 2011-04-08 |
| KR20110118812A (ko) | 2011-11-01 |
| AR075379A1 (es) | 2011-03-30 |
| TW201036979A (en) | 2010-10-16 |
| US20120071536A1 (en) | 2012-03-22 |
| WO2010092286A1 (fr) | 2010-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2017002I1 (no) | Cobicistat eller farmasøytisk akseptabelt salt derav og atazanavir eller farmasøytisk akseptabelt salt derav, spesielt atazanavirsulfat | |
| NO20091424L (no) | Substituerte amider, fremgangsmåte for fremstilling derav og anvendelse derav | |
| NO20091426L (no) | Substituerte amider, fremgangsmåte for fremstilling derav og anvendelse derav | |
| IT1392423B1 (it) | Struttura di guanto, in particolare da motociclismo, e metodo per la sua realizzazione. | |
| BRPI0821276A2 (pt) | Produto, e, uso do produto | |
| BR112013032803A8 (pt) | "derivados de n-[(1h-pirazol-1-il)aril]-1h-indol ou 1h-indazol-3-carboxamida, sua preparação e aplicação dos mesmos em terapêuticos" | |
| BRPI1015967A2 (pt) | "unidade de dobradiça, e, peça de mobília." | |
| FR2884516B1 (fr) | Antagonistes npy, preparation et utilisations | |
| BRPI0818144A2 (pt) | Produção de termolisin e variantes deste, e uso em detergentes líquidos | |
| DK2254927T3 (da) | Fugte- og dispergeringsmidler, disses fremstilling og anvendelse | |
| BRPI1014914A2 (pt) | Composição contendo trehalulose, sua preparação e uso | |
| BRPI1010621A2 (pt) | derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso | |
| BRPI0912807A2 (pt) | produto de aço inoxidável, uso do produto e método de sua fabricação | |
| BRPI0915552A2 (pt) | derivados de ciclosporina, seu uso e sua composição farmacêutica | |
| UY33079A (es) | Derivados de difenil -pirazolopiridinas, su preparación y su aplicación en terapeutica | |
| BRPI0814931A2 (pt) | Composto com atividade contra hcv, sua composição e seu uso | |
| BRPI0909828A2 (pt) | corantes dispersos de azopiridona, sua preparação e uso | |
| BRPI0822223A2 (pt) | Derivados de imidazo [1,2-alfa] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica | |
| IL193384A0 (en) | Substituted prolinamides, their preparation and their use as pharmaceuticals | |
| HK1134286A1 (en) | Aryl-and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics | |
| BRPI1008147A2 (pt) | composição de xampu concentrado e xampu centrado | |
| DK2310383T3 (da) | 2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
| BRPI0821482A2 (pt) | 3-n-fenil-1,3,4-oxadiazolona 5-o-substituída, seu uso, sua composição e seu processo de preparação | |
| HK1157363A1 (zh) | 抗伸展的型鞘糖脂抗體、其衍生物及用途 | |
| DOP2007000004A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |